US Patent 10925841 Epinephrine spray formulations
Patent 10925841 was granted and assigned to Bryn Pharma, LLC on February, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+210 characters)
Article
Patent abstract
Provided herein are epinephrine spray formulations. Also provided herein are methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatment.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Kenneth L. Dretchen0
Matthew P. Robben0
Michael Mesa0
Michelle Lobel0
Steven Hartman0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 10925841 Epinephrine spray formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10925841
Date of patent
February 23, 2021
Patent application number
16864183
Date Filed
May 1, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 10925841 Epinephrine spray formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.